目录肽产品
ATPE-001B
Atriopeptin I (rat)
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser(Cys&Cys Bridge)
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser(Cys&Cys Bridge)
Size：1
P1(RMB)：1190
MW：2083.29
One letter sequence：SSCFGGRIDRIGAQSGLGCNS(Cys&Cys bridge)
Molecular Formula：C83H135N29O30S2
Description：Atriopeptin is synthesized primarily in cardiac atria, acts in opposition to angiotensin II. When blood volume overload, Atriopeptin is released to act at the nephron to increase salt and water excretion, lowering blood volume and blood pressure.
Literature Reference：M.G.Currie et al., Science, 223, 67 (1984)
Cas：89139-53-7
P1(RMB)：1190
MW：2083.29
One letter sequence：SSCFGGRIDRIGAQSGLGCNS(Cys&Cys bridge)
Molecular Formula：C83H135N29O30S2
Description：Atriopeptin is synthesized primarily in cardiac atria, acts in opposition to angiotensin II. When blood volume overload, Atriopeptin is released to act at the nephron to increase salt and water excretion, lowering blood volume and blood pressure.
Literature Reference：M.G.Currie et al., Science, 223, 67 (1984)
Cas：89139-53-7
-
ADD杭州市钱塘区12号大街69号
-
TEL0571-86737011
-
E-mailsales@chinesepeptide.com
Copyright © 2024 js3983线路检测生化有限公司 All Rights Reserved.
浙ICP备05051877号-1
业务咨询和客户服务
企业微信公众号
